Le Lézard
Classified in: Health, Science and technology, Business
Subject: CXP

WuXi AppTec Opens Its New Medical Device Testing Center in Suzhou


SUZHOU, China, Nov. 16, 2018 /PRNewswire/ -- WuXi AppTec announces today that its Laboratory Testing Division's new Medical Device Testing Center opens today in Suzhou, China. This marks the full implementation of WuXi AppTec's medical device testing capabilities in the Chinese market, which works with its existing United States-based medical device testing centers in St. Paul and Atlanta to form a globally integrated medical device testing platform to serve medical device customers worldwide.

"WuXi AppTec's Laboratory Testing Division provides a world-class, globally integrated testing solution for drug and medical device development and manufacturing. We enable scientists to transform ideas into healthcare products, accelerate the development and commercialization from bench to bedside," said Dr. Jason Liu, Senior Vice President of WuXi AppTec and Chief Operating Officer of WuXi AppTec's Laboratory Testing Division. By providing integrated medical device testing and regulatory services from research and development to commercialization, WuXi AppTec's Laboratory Testing Division enables medical device companies to efficiently control product quality in its product life cycle from R&D to commercial sales.

The new medical device testing center operates in 15,000 square meters facility in Suzhou. Through the transfer of the capabilities, operation and quality management system of WuXi AppTec's United States-based Medical Device Testing Center, the new center will provide comprehensive medical device testing services that are in compliance with international quality standards. Its testing services will include biomaterials analysis, toxicology, biocompatibility, risk assessment, product aseptic design microbiology, physical testing of packaging and shelf life, product batch release testing and more. The new center will enable medical device companies worldwide to bring the leading medical and health products to patients in China and around the world.

About WuXi AppTec

WuXi AppTec is a leading global pharmaceutical and medical device open-access capability and technology platform company with global operations. As an innovation-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of services to help our worldwide customers and partners shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient solutions. With its industry-leading capabilities such as small molecule drug R&D and manufacturing, cell therapy and gene therapy R&D and manufacturing, drug R&D and medical device testing, WuXi platform is enabling more than 3,000 innovative collaborators from more than 30 countries to bring innovative healthcare products to patients, and to fulfill WuXi's dream that "every drug can be made and every disease can be treated."  

SOURCE WuXi AppTec


These press releases may also interest you

at 20:00
SysInformation Healthcare Services, LLC ("SysInformation"), d/b/a EqualizeRCM and 1st Credentialing, is providing notice of a recent data security event that may affect the security of information related to certain individuals. SysInformation is...

at 19:32
Scottie Resources Corp. ("Scottie" or the "Company") announces that it has granted 7,400,000 options to acquire common shares to certain directors, officers, and consultants to the Company. The options are exercisable at a price of $0.195 per...

at 19:31
DaVita Inc. , announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 2, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is...

at 18:05
As part of its ongoing mission to meet the growing need for emergency services in metro Atlanta, Grady Health System will build a freestanding emergency department in south Fulton County. This freestanding emergency department, built in partnership...

at 18:00
Digicann Ventures Ltd. ("Digicann" or the "Company") , a company focused on opportunities within and outside of the cannabis industry, announces that it has entered into an agreement with holders of the Company's 10.00% Senior Unsecured Convertible...

at 18:00
Beauty-Stem, a subsidiary of Power-Stem Biomedical, has been at the forefront of stem cell research and development since its parent company's inception in Taiwan back in 2005. With...



News published on and distributed by: